594
Views
22
CrossRef citations to date
0
Altmetric
Review

Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective

Pages 41-52 | Published online: 05 Jun 2018

References

  • KellermanRKintanarTGastroesophageal reflux diseasePrim Care201744456157329132520
  • VakilNvan ZantenSVKahrilasPDentJJonesRGlobal Consensus GroupThe Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensusAm J Gastroenterol200610181900192016928254
  • PeeryAFDellonESLundJBurden of gastrointestinal disease in the United States: 2012 updateGastroenterology201214351179118722885331
  • OkimotoEIshimuraNMoritoYPrevalence of gastroesophageal reflux disease in children, adults, and elderly in the same communityJ Gastroenterol Hepatol20153071140114625611309
  • Ness-JensenELindamALagergrenJHveemKChanges in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT studyGut201261101390139722190483
  • IwakiriKKinoshitaYHabuYEvidence-based clinical practice guidelines for gastroesophageal reflux disease 2015J Gastroenterol201651875176727325300
  • RubensteinJHChenJWEpidemiology of gastroesophageal reflux diseaseGastroenterol Clin North Am201443111424503355
  • HarrisonCHendersonJMillerGBrittHThe prevalence of diagnosed chronic conditions and multimorbidity in Australia: a method for estimating population prevalence from general practice patient encounter dataPLoS One2017123e017293528278241
  • BashashatiMSarosiekIMcCallumRWEpidemiology and mechanisms of gastroesophageal reflux disease in the elderly: a perspectiveAnn N Y Acad Sci20161380123023427526197
  • SavarinoEde BortoliNDe CassanCThe natural history of gastro-esophageal reflux disease: a comprehensive reviewDis Esophagus201730219
  • PohlHWelchHGThe role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidenceJ Natl Cancer Inst200597214214615657344
  • HerregodsTVBredenoordAJSmoutAJPathophysiology of gastro-esophageal reflux disease: new understanding in a new eraNeurogastroenterol Motil20152791202121326053301
  • Ness-JensenELagergrenJTobacco smoking, alcohol consumption and gastro-oesophageal reflux diseaseBest Pract Res Clin Gastroenterol201731550150829195669
  • VasapolliRMalfertheinerPKandulskiAHelicobacter pylori and nonmalignant upper gastrointestinal diseasesHelicobacter201621Suppl 1303327531536
  • BodyCChristieJAGastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrheaGastroenterol Clin North Am201645226728327261898
  • BöhmerACSchumacherJInsights into the genetics of gastroesophageal reflux disease (GERD) and GERD-related disordersNeurogastroenterol Motil201729213017
  • Moraes-FilhoJPRefractory gastroesophageal reflux diseaseArq Gastroenterol201249429630123329226
  • ZografosGNGeorgiadouDThomasDKaltsasGDigalakisMDrug-induced esophagitisDis Esophagus200922863363719392845
  • TutuianRAdverse effects of drugs on the esophagusBest Pract Res Clin Gastroenterol2010242919720227023
  • FletcherJWirzAYoungJVallanceRMcCollKEUnbuffered highly acidic gastric juice exists at the gastroesophageal junction after a mealGastroenterology2001121477578311606490
  • WuJLiuDFengCThe characteristics of postprandial proximal gastric acid pocket in gastroesophageal reflux diseaseMed Sci Monit20182417017629309401
  • TytgatGNMcCollKTackJNew algorithm for the treatment of gastro-oesophageal reflux diseaseAliment Pharmacol Ther200827324925617973975
  • TalleyNJFunctional dyspepsia: advances in diagnosis and therapyGut Liver201711334935728452210
  • DrossmanDAHaslerWLRome IV-functional GI disorders: disorders of gut-brain interactionGastroenterology201615061257126127147121
  • YamawakiHFutagamiSWakabayashiMManagement of functional dyspepsia: state of the art and emerging therapiesTher Adv Chronic Dis201891233229344328
  • HoltmannGBigardMAMalfertheinerPPounderRGuidance on the use of over-the-counter proton pump inhibitors for the treatment of GERDInt J Clin Pharm201133349350021472476
  • SouzaRFReflux esophagitis and its role in the pathogenesis of Barrett’s metaplasiaJ Gastroenterol201752776777628451845
  • PanarelliNCOther forms of esophagitis: it is not gastroesophageal reflux disease, so now what do I do?Surg Pathol Clin201710476577929103532
  • SmithCDEsophageal strictures and diverticulaSurg Clin North Am201595366968125965138
  • KhanAKimASanossianCFrancoisFImpact of obesity treatment on gastroesophageal reflux diseaseWorld J Gastroenterol20162241627163826819528
  • ManabeNHarumaKItoMEfficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trialDis Esophagus201225537338022050449
  • ReimerCLødrupABSmithGWilkinsonJBytzerPRandomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitorAliment Pharmacol Ther201643889990926909885
  • PouchainDBigardMLiardFChildsMDecaudinAMcVeyDGaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. A direct comparative randomised trialBMC Gastroenterol2012121822361121
  • DettmarPWHampsonFCTaubelJThe suppression of gastro-esophageal reflux by alginatesInt J Clin Pract200761101654166217681004
  • StrandDSKimDPeuraDA25 Years of proton pump inhibitors: a comprehensive reviewGut Liver2017111273727840364
  • GrahamDYTanselAInterchangeable use of proton pump inhibitors based on relative potencyClin Gastroenterol Hepatol2017 Epub928
  • LiMJLiQSunMLiuLQComparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: a PRISMA-compliant network meta-analysisMedicine (Baltimore)20179639e812028953640
  • IwakiriKTreatment strategy for standard-dose proton pump inhibitor-resistant reflux esophagitisJ Nippon Med Sch201784520921429142181
  • AiolfiAAstiEBernardiDEarly results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and meta-analysisInt J Surg201852828829471155
  • KimSESofferEElectrical stimulation for gastroesophageal reflux disease: current state of the artClin Exp Gastroenterol20169111926834494
  • FreedbergDEKimLSYangYXThe risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological AssociationGastroenterology2017152470671528257716
  • EusebiLHRabittiSArtesianiMLProton pump inhibitors: risks of long-term useJ Gastroenterol Hepatol20173271295130228092694
  • HuQSunTTHongJFangJYXiongHMeltzerSJProton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a systematic review and meta-analysisPLoS One2017121e016969128072858
  • WilsdonTDHendrixIThynneTRMangoniAAEffectiveness of interventions to deprescribe inappropriate proton pump inhibitors in older adultsDrugs Aging201734426528728220380
  • NauntonMPetersonGMDeeksLSYoungHKosariSWe have had a gutful: the need for deprescribing proton pump inhibitorsJ Clin Pharm Ther2018431657228895169
  • BoghossianTARashidFJThompsonWDeprescribing versus continuation of chronic proton pump inhibitor use in adultsCochrane Database Syst Rev20173CD011969
  • WedemeyerRSBlumeHPharmacokinetic drug interaction profiles of proton pump inhibitors: an updateDrug Saf201437420121124550106
  • StollbergerCDrug interactions with new oral anticoagulants in elderly patientsExpert Rev Clin Pharmacol201710111191120228825849
  • ShamliyanTAMiddletonMBorstCPatient-centered outcomes with concomitant use of proton pump inhibitors and other drugsClin Ther201739240442728189362
  • McCabeSMSmithPFMaQMorseGDDrug interactions between proton pump inhibitors and antiretroviral drugsExpert Opin Drug Metab Toxicol20073219720717428151
  • WicińskiMWęclewiczMMMiętkiewiczMMalinowskiBGrześkEKlonowskaJPotential mechanisms of hematological adverse drug reactions in patients receiving clozapine in combination with proton pump inhibitorsJ Psychiatr Pract201723211412028291036
  • IaniroGMangiolaFDi RienzoTALevothyroxine absorption in health and disease, and new therapeutic perspectivesEur Rev Med Pharmacol Sci201418445145624610609
  • LeimanDARiffBPMorganSAlginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysisDis Esophagus201730519
  • SavarinoEZentilinPMarabottoEA review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)Expert Opin Pharmacother201718131333134328754071
  • ZhangJXJiMYSongJProton pump inhibitor for non-erosive reflux disease: a meta-analysisWorld J Gastroenterol201319458408841924363534
  • ShinJMSachsGPharmacology of proton pump inhibitorsCurr Gastroenterol Rep200810652853419006606
  • RichterJEKumarALipkaSMiladinovicBVelanovichVEfficacy of laparoscopic nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysisGastroenterology201815451298130829305934